FB_Lockup.png
FirstBank Maintains Robust Growth at the Start of 2022
May 09, 2022 11:00 ET | FirstBank
LAKEWOOD, Colo., May 09, 2022 (GLOBE NEWSWIRE) -- FirstBank, one of the nation’s largest privately held banks with a focus on “banking for good,” announced its 2022 first quarter summary on the...
PCS logo experts.png
PCS Edventures! Reports Unaudited Results for the Third Quarter of Fiscal Year 2022
February 15, 2022 15:22 ET | PCS Edventures!, Inc.
BOISE, Idaho, Feb. 15, 2022 (GLOBE NEWSWIRE) -- PCS Edventures!, Inc., (PCSV) a leading provider of K-12 Science, Technology, Engineering and Mathematics (STEM) education programs and drone...
BIONEX™ Technology Installation
Clean TeQ Water's Second Quarterly Results After Listing on ASX Show Accelerating Cash Receipts From Its Technology Portfolio
February 01, 2022 07:00 ET | Clean TeQ Water
MELBOURNE, Australia, Feb. 01, 2022 (GLOBE NEWSWIRE) -- Clean TeQ Water's (ASX:CNQ) recently released its December 2021 Quarterly Report, which showed cash receipts of A$3.8 million, a 138% increase...
CEO Anders H. Nørgaard
Delårsrapport for 1. januar - 30. september 2021 for FirstFarms A/S
November 24, 2021 02:47 ET | FirstFarms A/S
Tilfredsstillende 3. kvartal peger i retning af historisk 2021-resultatDe høje priser på afgrøder har påvirket FirstFarms A/S resultat positivt i de første 3 kvartaler af 2021, da FirstFarms på...
CEO Anders H. Nørgaard
Interim financial report for 1 January - 30 September 2021 for FirstFarms A/S
November 24, 2021 02:47 ET | FirstFarms A/S
Satisfactory Q3 points to historic 2021 result The prices of crops have affected FirstFarms A/S' result in the first 3 quarters of 2021 positively, as FirstFarms annually is a large net seller...
Immatics Final logo (R)_white_background.png
Immatics veröffentlicht Ergebnisse des dritten Quartals 2021 sowie ein Update zur Geschäftsentwicklung
November 16, 2021 07:00 ET | Immatics N.V.
Laufende ACTengine® IMA203-Studie: Zelltherapie gegen PRAME erzielt therapeutischen Anti-Tumor-Effekt in verschiedenen soliden Tumoren bereits in Dosis-EskalationsphaseImmatics plant drei...
Immatics Final logo (R)_white_background.png
Immatics Announces Third Quarter 2021 Financial Results and Provides Business Update
November 16, 2021 07:00 ET | https://immatics.com/
Interim data update at SITC for ongoing ACTengine® IMA203 trial targeting PRAME demonstrated clinical responses across multiple solid tumor types during dose escalation phaseImmatics to initiate three...
Picture of a Clean TeQ Water Treatment Plant
Australian Water Technology Company Shows Rapid Growth in First Quarter as a Public Company
November 09, 2021 19:07 ET | Clean TeQ Water
MELBOURNE, Australia, Nov. 10, 2021 (GLOBE NEWSWIRE) -- Clean TeQ Water recently released its first quarterly report since publicly listing on the Australian Securities Exchange. It currently has...
GenTech-Colour-Trans-800x400.png
GenTech Posts Strong Quarterly Report Featuring Breakout Growth in Revenues & Inventory on Hand coupled with large Decreases in Liabilities
September 15, 2021 09:15 ET | GenTech Holdings Inc.
NEW YORK, Sept. 15, 2021 (GLOBE NEWSWIRE) -- GenTech Holdings, Inc. (OTC Pink: GTEH) (“GenTech” or the “Company”), an emerging leader in the Functional Foods and Nutritional Supplement marketplaces,...
Immatics Final logo (R)_white_background.png
Immatics veröffentlicht Ergebnisse des zweiten Quartals 2021 sowie ein Update zur Geschäftsentwicklung
August 10, 2021 07:00 ET | Immatics N.V.
Patientenrekrutierung für die ACTengine®-Studien verläuft weiterhin nach Plan; bis Ende Juli wurden insgesamt 27 Patienten mit unterschiedlichen Krebserkrankungen mit den Produktkandidaten IMA201,...